Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

NCT07530679 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Cancer Prevention

Interventions

BIOLOGICAL: 9-valent HPV vaccination at months 0 and 6
BIOLOGICAL: 9-valent HPV vaccination at months 0 , 1 and 6

Sponsor

Jiangsu Province Centers for Disease Control and Prevention